Top compounds associated with response to ERVK3-1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	5-FU	CTRPv2	pan-cancer	AAC	-0.091	0.009
mRNA	triptolide	CTRPv2	pan-cancer	AAC	-0.094	0.009
mRNA	Bortezomib	CTRPv2	pan-cancer	AAC	0.091	0.01
mRNA	PRL-3 Inhibitor I	CTRPv2	pan-cancer	AAC	-0.1	0.01
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.088	0.02
mRNA	docetaxel:tanespimycin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.079	0.02
mRNA	BRD-A02303741:carboplatin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.09	0.02
mRNA	AZD-2281	CTRPv2	pan-cancer	AAC	-0.082	0.02
mRNA	BRD-K33514849	CTRPv2	pan-cancer	AAC	0.28	0.02
mRNA	BRD-A05715709	CTRPv2	pan-cancer	AAC	-0.13	0.02

Download CSV